Literature DB >> 1488122

Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow.

S Ceccatelli1, J M Lundberg, J Fahrenkrug, D S Bredt, S H Snyder, T Hökfelt.   

Abstract

Vasoactive intestinal polypeptide and peptide histidine isoleucine, two peptides with a common precursor and with strong vasodilatory actions, have been suggested to be involved in control of blood flow through the hypothalamic portal blood vessels, in this way regulating the amounts of releasing and inhibitory factors reaching the anterior pituitary. Using the indirect immunofluorescence technique, we now show that this system also contains the enzyme nitric oxide synthase, as well as acetylcholinesterase. It is therefore likely that the control of blood flow through the portal vessels is mediated via relaxation of smooth muscle cells with a high myogenic tone by neuronal release of four vasodilatory compounds, acetylcholine, vasoactive intestinal polypeptide, peptidine histidine isoleucine, and nitric oxide, i.e. a classic neurotransmitter, two neuropeptides and a gas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488122     DOI: 10.1016/0306-4522(92)90518-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Selective inhibitors of nitric oxide synthase (NOS) implicate a constitutive isoform of NOS in the regulation of interleukin-1-induced ACTH secretion in rats.

Authors:  A V Turnbull; C Rivier
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

2.  Pulmonary effects of endogenous and exogenous nitric oxide in the pig: relation to cigarette smoke inhalation.

Authors:  K Alving; C Fornhem; J M Lundberg
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

Review 3.  Drinking Water Nitrate and Human Health: An Updated Review.

Authors:  Mary H Ward; Rena R Jones; Jean D Brender; Theo M de Kok; Peter J Weyer; Bernard T Nolan; Cristina M Villanueva; Simone G van Breda
Journal:  Int J Environ Res Public Health       Date:  2018-07-23       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.